Summary of Methods {#Sec1}
==================

Human Coronaviruses (HCoVs) are recognised to be an important cause of the common cold. In 1962 HCoV-229E and HCoV-OC43 where first recognised, more recently HCoV-NL63 and HCoV-HKU-1 have been discovered in respiratory specimens from children and adults \[[@CR3]\]. This protocol describes two real-time reverse-transcriptase polymerase chain reaction (RT-PCR) methods, a single target and triplex RT-PCR that identifies and differentiates HCoV infection.

Acceptable Specimens {#Sec2}
====================

Respiratory specimens (Nasopharyngeal aspirates, nose and throat swabs and bronchial samples).

Sample Extraction {#Sec3}
=================

Respiratory specimens (200 μl) were extracted using the QIAGEN QIAxtractor, as per manufacturer's instructions giving a final volume of 50 μl.

Primer and Probe Sequences {#Sec4}
==========================

Primers and probe targets were obtained from previously published articles \[[@CR1]--[@CR3]\] (Table [42.1](#Tab1){ref-type="table"}). Table 42.1Sequence details of primers and probes, used for the detection of human coronaviruses by real-time PCROligonucleotidesSequence (5^′^--3^′^)Target geneRefs.***Single Target***Replicase 1b(2)HCoV-HKU-1-FCCTTGCGAATGAATGTGCTHCoV-HKU-1-RTTGCATCACCACTGCTAGTACCACHCoV-HKU-1-RFAM--TGTGTGGCGGTTGCTATTATGTTAAGCCTG-BHQ-1***Triplex RT-PCR***HCoV-229E-FCAGTCAAATGGGCTGATGCAHCoV-229E-RAAAGGGCTATAAAGAGAATAAGGTATTCTN gene(1)HCoV-229E-PrFAM-CCCTGACGACCACGTTGTGGTTCA-BHQHCoV-OC43-FCGATGAGGCTATTCCGACTAGGTHCoV-OC43-RCCTTCCTGAGCCTTCAATATAGTAACCN gene(1)HCoV-OC43-PrQUASAR-TCCGCCTGGCACGGTACTCCCT-BHQHCoV-NL63-FACGTACTTCTATTATGAAGCATGATATTAAHCoV-NL63-RAGCAGATCTAATGTTATACTTAAAACTACG1a gene(3)HCoV-NL63-PrVIC-ATTGCCAAGGCTCCTAAACGTACAGGTGTT-TAMRA (300)

PCR Amplification and Product Detection {#Sec5}
=======================================

The first assay contains a single target for HCoV-HKU1, the conserved primer and probe sequences are found in the replicase 1b gene. The second assay detects three HCoV strains, HCoV-229E, HCoV-OC43 both contain target sequences in the N gene, and HCoV-NL63 which target sequences are in the 1a gene (Table [42.1](#Tab1){ref-type="table"}). Both assays are performed using the QIAGEN One-step RT-PCR kit (QIAGEN, Australia) comprising 0.8 μM of forward and reverse primers (HCoV-HKU-1-F and HCoV-HKU1-R for the single target PCR and the triplex HCoV-229E-F, HCoV-229E-R, HCoV-OC43-F, HCoV-OC43-R, HCoV-NL63-F and HCoV-NL63-R) (Table [42.1](#Tab1){ref-type="table"}), 0.2 μM of TaqMan probe (single target PCR, HCoV-HKU1-Pr and in the triplex HCoV-229E-Pr, HCoV-OC43-Pr and HCoV-NL63-Pr) (Table [42.1](#Tab1){ref-type="table"}), in a total reaction volume of 25 μl including 5 μl of sample RNA. Both amplification reactions were performed on the RotorGene 3000 or 6000 (QIAGEN, Australia) using the following parameters; initial RT incubation of 20 min at 50°C, followed by 50 cycles of 95°C for 15 s, and 60°C for 1 min, with fluorescence acquired at the end of each 60°C step.

Quality Control and Validation Data {#Sec6}
===================================

The single target HCoV-HKU1 assay was validated using 31 clinical specimens positive for HCoV, detected using various different techniques. No cross reaction was detected to samples positive for other respiratory pathogens. Sensitivity was measured by serial titration, 15 replicates where tested with 100% detection at 50 copies and 33.3% at 5 copies \[[@CR1]\].

The HCoV triplex was validated by ATCC positive specimens for each strain. Each positive was tested as an individually target and in the triplex reaction with no loss of sensitivity or cross reaction between strains \[[@CR2]\].
